You are here

Press releases

24.02.2023

Barcelona, February 24, 2023.- In recent years, Catalonia has seen rapid growth in the number of digital health firms and 2022 confirmed that upward trend. While in 2010 there were only about 20 companies in the BioRegion, 12 years later there are 212: a tenfold increase in the number of innovative companies. This increase is reflected in the youth and explosive growth of this subsector, with joint turnover of €356 million, as shown in the 2022 BioRegion of Catalonia...

13.02.2023

Barcelona, February 13, 2023. In a year that looked uncertain at the start given the general drop in investment and valuations in markets worldwide, health startups and scaleups in Catalonia have once again set all-time records, securing €445 million in investment. Funding through venture capital was again the main driver of this growth, with more than €343 million in total or 77% of all capital raised.

Foreign investment also continued to hit new highs. 95% of the venture capital raised was in operations with international investors. This brought...

17.01.2023

Barcelona, 17 January 2023. - The Spanish Bioindustry Association (AseBio) and Biocat presented BIOSPAIN 2023 this Tuesday at the Barcelona Science Park, in collaboration with the Government of Catalonia and Barcelona City Council. Now 20 years after the first edition, BIOSPAIN has consolidated its place as a benchmark international event for the biotechnology sector. The congress is a complete showcase for all the potential of this industry and its presence in all arenas of society, offering specific...

26.07.2022

Barcelona, July 26, 2022. -Investment in health startups in the BioRegion of Catalonia set a new record in the first half of the year: €296 million, more than all funding secured in 2021 (€238 million). This period (January to July) was the best ever, fueled once again by venture capital, which totaled €258 million, or 87% of the capital raised, followed by the stock market, public grants and crowdequity.

 

...
18.05.2022

Barcelona, 18 May 2022.- Catalonia is participating in over 1,200 clinical trials currently underway to test new therapies and drugs in patients. This puts the BioRegion 6th in Europe in number of trial participations and 8th in the world.

Catalonia is only surpassed in number of participations in active studies by large countries like the United States (9,532), Canada (1,905), France (1,896), United Kingdom (1,633), Spain (1,595), Germany (1,583) and Italy (1,460). The data also shows that Catalan centers take part in 75% of all active trials run in Spain,...

10.05.2022

Tuesday, 10 May 2022, Madrid and Barcelona. - The Spanish Bioindustry Association (AseBio) announced this Tuesday that BIOSPAIN, one of the biggest international biotechnology events in southern Europe, will take place from 26 to 28 September 2023 in Barcelona, in collaboration with Biocat, the Government of Catalonia and the Barcelona City Council.  

For Biocat CEO Robert Fabregat, Barcelona being chosen to host BIOSPAIN “confirms the Catalan capital’s strategic position as one of the main cities on the map for life sciences and...